Clinical trials
Phase 3 trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,876 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 23 |
| 2004 | 30 |
| 2005 | 59 |
| 2006 | 101 |
| 2007 | 130 |
| 2008 | 137 |
| 2009 | 105 |
| 2010 | 122 |
| 2011 | 93 |
| 2012 | 56 |
| 2013 | 55 |
| 2014 | 43 |
| 2015 | 37 |
| 2016 | 50 |
| 2017 | 62 |
| 2018 | 74 |
| 2019 | 64 |
| 2020 | 89 |
| 2021 | 93 |
| 2022 | 84 |
| 2023 | 97 |
| 2024 | 89 |
| 2025 | 85 |
| 2026 | 72 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,162 |
| Recruiting | 209 |
| Active, not recruiting | 206 |
| Terminated | 168 |
| Unknown status | 85 |
| Not yet recruiting | 24 |
| Withdrawn | 13 |
| Enrolling by invitation | 5 |
| Suspended | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 173 |
| Novartis Pharmaceuticals | 139 |
| Eli Lilly and Company | 104 |
| Novo Nordisk A/S | 97 |
| Boehringer Ingelheim | 71 |
| Pfizer | 70 |
| GlaxoSmithKline | 63 |
| Sanofi | 63 |
| Bristol-Myers Squibb | 45 |
| Hoffmann-La Roche | 45 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 195 |
| Diabetes Mellitus | 86 |
| Carcinoma, Non-Small-Cell Lung | 80 |
| Breast Neoplasms | 77 |
| Pulmonary Disease, Chronic Obstructive | 43 |
| Obesity | 35 |
| Schizophrenia | 33 |
| Cardiovascular Diseases | 32 |
| Neoplasms | 31 |
| Renal Insufficiency, Chronic | 31 |
Trials
Showing 1 to 25 of 1,876. Each trial links to its page on Pharma Observatory.
1,776 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.